Cardiff Oncology Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2009
Revenue	0.49	0.39	0.36	0.37	0.24	Upgrade
Revenue Growth (YoY)	26.42%	7.52%	-1.91%	49.61%	-35.34%	Upgrade
Gross Profit	0.49	0.39	0.36	0.37	0.24	Upgrade
Selling, General & Admin	13.04	13.18	11.84	8.22	5.76	Upgrade
Research & Development	32.86	27.11	17.38	11.24	11.16	Upgrade
Other Operating Expenses	0	0	0	0	-0	Upgrade
Operating Expenses	45.9	40.29	29.21	19.45	16.92	Upgrade
Operating Income	-45.41	-39.9	-28.86	-19.09	-16.68	Upgrade
Interest Expense / Income	0	0	0	0	0	Upgrade
Other Expense / Income	-3.97	-1.2	-0.56	0.22	-0.26	Upgrade
Pretax Income	-41.44	-38.7	-28.29	-19.31	-16.41	Upgrade
Net Income	-41.44	-38.7	-28.29	-19.31	-16.41	Upgrade
Preferred Dividends	0.02	0.02	0.02	3.29	0.29	Upgrade
Net Income Common	-41.47	-38.73	-28.32	-22.6	-16.71	Upgrade
Shares Outstanding (Basic)	45	44	39	21	6	Upgrade
Shares Outstanding (Diluted)	45	44	39	21	6	Upgrade
Shares Change	2.47%	11.71%	86.97%	249.44%	156.37%	Upgrade
EPS (Basic)	-0.93	-0.89	-0.73	-1.08	-2.80	Upgrade
EPS (Diluted)	-0.93	-0.89	-0.73	-1.08	-2.80	Upgrade
Free Cash Flow	-31.47	-34.83	-23.25	-16.53	-13.34	Upgrade
Free Cash Flow Per Share	-0.70	-0.80	-0.60	-0.79	-2.23	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-9305.74%	-10337.31%	-8037.60%	-5214.75%	-6816.98%	Upgrade
Profit Margin	-8496.93%	-10033.16%	-7887.19%	-6174.32%	-6829.31%	Upgrade
Free Cash Flow Margin	-6448.57%	-9022.28%	-6474.93%	-4515.30%	-5451.09%	Upgrade
EBITDA	-41.04	-38.47	-27.84	-18.84	-15.92	Upgrade
EBITDA Margin	-8410.45%	-9965.80%	-7754.87%	-5147.27%	-6507.70%	Upgrade
Depreciation & Amortization	0.4	0.24	0.45	0.47	0.49	Upgrade
EBIT	-41.44	-38.7	-28.29	-19.31	-16.41	Upgrade
EBIT Margin	-8492.01%	-10026.94%	-7880.50%	-5274.59%	-6709.74%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).